Identification of a clinicopathologic prognostic index for newly diagnosed large B cell lymphoma patients treated with R-CHOP
Not available.
Saved in:
| Main Authors: | Vincent Ni, Sunita D. Nasta, Stefan K. Barta, Stephen J. Schuster, Elise A. Chong, Jakub Svoboda, Jennifer J.D. Morrissette, Ashley Barlev, Adam Bagg, Salvatore F. Priore, Daniel J. Landsburg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2024-11-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11853 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma
by: Nikita K. Dave, et al.
Published: (2025-08-01) -
CHOP is insufficient for newly-diagnosed subcutaneous panniculitis-like T-cell lymphoma patients: a retrospective study of 32 patients in China
by: Chao Chen, et al.
Published: (2025-07-01) -
Zanubrutinib plus R-CHOP improves the treatment effect of newly diagnosed diffuse large B cell lymphoma with double expression of MYC and BCL-2
by: Min Zhang, et al.
Published: (2025-03-01) -
Screening of Probiotics Derived from Chopped Chili and Its Application in Fermented Chopped Chili
by: Qian YANG, et al.
Published: (2025-02-01) -
Outcome of R-CHOP or CHOP Regimen for Germinal Center and Nongerminal Center Subtypes of Diffuse Large B-Cell Lymphoma of Chinese Patients
by: Ying Huang, et al.
Published: (2012-01-01)